Article citationsMore>>

Guazzi, M., Samaja, M., Arena, R., et al. (2007) Long-term use of sildenafil in the therapeutic management of heart failure. Journal of the American College of Cardiology, 50, 2136-2144. doi:10.1016/j.jacc.2007.07.078

has been cited by the following article:

• TITLE: Combined phosphodiesterase inhibitors in end-stage heart failure: A case presentation

  AUTHORS: Javier Reyna, Julio G. Peguero, Esteban Escolar, Orlando Santana, Gervasio A. Lamas

  KEYWORDS: Heart Failure; Phosphodiesterase Inhibitors

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.3 No.3, June 4, 2013

  ABSTRACT: Heart failure (HF) is the leading cause of morbidity and mortality and is evolving to epidemic proportions. Despite pharmacologic advances and device interventions, HF remains a progressive disease. The phosphodiesterase inhibitors-3 (PDE3I), and more recently, the phosphodiesterase inhibitors-5 (PDE5I) have been used as part of the treatment in certain patients, however, such combination has not been studied or reported before.